Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 1/2 1

Status

Active not recruiting 3Terminated 2Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 8OTHER 1INDIV 1

Study Type

Interventional 8

Sponsor

Conditions

Neoplasms 1520Carcinoma, Non-Small-Cell Lung 754Breast Neoplasms 572Neoplasm Metastasis 529Colorectal Neoplasms 445Melanoma 391Leukemia, Myeloid, Acute 371Multiple Myeloma 363Ovarian Neoplasms 352Recurrence 336Lymphoma 334Advanced Solid Tumors 324Lymphoma, Non-Hodgkin 314Prostatic Neoplasms 300Pancreatic Neoplasms 285Advanced Solid Tumor 240Stomach Neoplasms 232Carcinoma, Renal Cell 225Squamous Cell Carcinoma of Head and Neck 210Lung Neoplasms 210Solid Tumor 204Leukemia, Lymphocytic, Chronic, B-Cell 198Triple Negative Breast Neoplasms 183Solid Tumors 182Carcinoma, Hepatocellular 164Hematologic Neoplasms 155Head and Neck Neoplasms 152Lymphoma, Large B-Cell, Diffuse 148Lymphoma, Follicular 146Glioblastoma 145

Interventions

SH-1028 1Injections 12-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-5-(2-hydroxy-3-morpholinopropyl)-3-methyl-5,6,7,8-tetrahydro-1H-pyrrolo(3,2-c)azepin-4-ketone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Advanced Solid Cancer × Clear all
NCT05947474 2026-02-10

ORB

Orionis Biosciences Inc

Phase 1 Active not recruiting
55 enrolled

Advanced Solid Cancer

NCT07265921 2025-12-05

Solid Tumors

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting
232 enrolled

Advanced Solid Cancer

NCT07196579 2025-09-29

Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors

TCRx Therapeutics Co.Ltd

Phase 1 Not yet recruiting
30 enrolled

Advanced Solid Cancer

NCT04877717 2025-03-25

A Study of SHR-A1904 in Patients With Advanced Solid Cancer

Shanghai Hengrui Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
107 enrolled

Advanced Solid Cancer

NCT03791112 2025-01-27

A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor

Betta Pharmaceuticals Co., Ltd.

Phase 1 Active not recruiting
54 enrolled

Advanced Solid Cancer

NCT03884517 2023-05-01

Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer

Bio-Thera Solutions

Phase 1 Terminated
5 enrolled

Advanced Solid Cancer

NCT03618043 2019-01-29

Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer

Nanjing Sanhome Pharmaceutical, Co., Ltd.

Phase 1 Unknown
14 enrolled

Advanced Solid Cancer

NCT01416623 2012-12-21

A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Terminated
44 enrolled

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡